BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reynolds WS, Dmochowski R, Wein A, Bruehl S. Does central sensitization help explain idiopathic overactive bladder? Nat Rev Urol 2016;13:481-91. [PMID: 27245505 DOI: 10.1038/nrurol.2016.95] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Kwon J, Lee EJ, Park HR, Cho HJ, Jang JA, Yang H, An J, Park D, Kim YJ, Hur KJ, Kim JS, Yoshimura N. Continuous administration of mirabegron has advantages in inhibition of central sensitization compared with short-term treatment cessation in a mouse model of overactive bladder. Neurourol Urodyn 2022. [PMID: 35556260 DOI: 10.1002/nau.24956] [Reference Citation Analysis]
2 Senel C, Kizilay YO, Turan K, Ongun S, Tuzel E. Does total knee arthroplasty affect overactive bladder symptoms in female patients? Int Urogynecol J 2022. [PMID: 35212786 DOI: 10.1007/s00192-022-05121-9] [Reference Citation Analysis]
3 Barbosa JMM, de Amorim JSC, de Jesus Moraleida FR, Rocha VTM, Silva JPD, de Professor BZ, Felício DC, Assis MG, Pereira LSM. Urinary symptoms in older people with low back pain: Prevalence, clinical, and functional factors associated. Neurourol Urodyn 2021;40:1999-2007. [PMID: 34481418 DOI: 10.1002/nau.24782] [Reference Citation Analysis]
4 Senders A, Bauer SR, Chen Y, Oken B, Fink HA, Lane NE, Sajadi KP, Marshall LM, For The Osteoporotic Fractures In Men MrOS Study Group. Lower urinary tract symptoms are associated with musculoskeletal pain among older men: Preliminary evidence for central sensitization as a mechanism? Neurourol Urodyn 2021. [PMID: 34396562 DOI: 10.1002/nau.24767] [Reference Citation Analysis]
5 Andersson KE, Christ GJ, Davies KP, Rovner ES, Melman A. Gene Therapy for Overactive Bladder: A Review of BK-Channel α-Subunit Gene Transfer. Ther Clin Risk Manag 2021;17:589-99. [PMID: 34113116 DOI: 10.2147/TCRM.S291798] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Peng HY, Lai CY, Hsieh MC, Lin TB. Solifenacin/Mirabegron Induces an Acute Compliance Increase in the Filling Phase of the Capacity-Reduced Urinary Bladder: A Pressure-Volume Analysis in Rats. Front Pharmacol 2021;12:657959. [PMID: 34122078 DOI: 10.3389/fphar.2021.657959] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Lenoir D, Willaert W, Coppieters I, Malfliet A, Ickmans K, Nijs J, Vonck K, Meeus M, Cagnie B. Electroencephalography During Nociceptive Stimulation in Chronic Pain Patients: A Systematic Review. Pain Med 2020;21:3413-27. [PMID: 32488229 DOI: 10.1093/pm/pnaa131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Walter M, Leitner L, Betschart C, Engeler DS, Freund P, Kessler TM, Kollias S, Liechti MD, Scheiner DA, Michels L, Mehnert U. Considering non-bladder aetiologies of overactive bladder: a functional neuroimaging study. BJU Int 2021;128:586-97. [PMID: 33547746 DOI: 10.1111/bju.15354] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Przydacz M, Golabek T, Dudek P, Skalski M, Sobanski J, Klasa K, Gronostaj K, Dudek D, Chlosta P. Overactive Bladder Symptoms Negatively Affect Sleep Quality of Patients With Depression. Int Neurourol J 2021;25:59-68. [PMID: 33504134 DOI: 10.5213/inj.2040110.055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Bautrant E, Franké O, Amiel C, Bensousan T, Thiers-Bautrant D, Levêque C. Treatment of acute dysmenorrhoea and pelvic pain syndrome of uterine origin with myometrial botulinum toxin injections under hysteroscopy: A pilot study. J Gynecol Obstet Hum Reprod 2021;50:101972. [PMID: 33186771 DOI: 10.1016/j.jogoh.2020.101972] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Felde G, Engeland A, Hunskaar S. Urinary incontinence associated with anxiety and depression: the impact of psychotropic drugs in a cross-sectional study from the Norwegian HUNT study. BMC Psychiatry 2020;20:521. [PMID: 33138789 DOI: 10.1186/s12888-020-02922-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Huang SN, Wei J, Huang LT, Ju PJ, Chen J, Wang YX. Bulleyaconitine A Inhibits Visceral Nociception and Spinal Synaptic Plasticity through Stimulation of Microglial Release of Dynorphin A. Neural Plast 2020;2020:1484087. [PMID: 32565774 DOI: 10.1155/2020/1484087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Panicker JN, Marcelissen T, von Gontard A, Vrijens D, Abrams P, Wyndaele M. Bladder-bowel interactions: Do we understand pelvic organ cross-sensitization? International Consultation on Incontinence Research Society (ICI-RS) 2018. Neurourol Urodyn 2019;38 Suppl 5:S25-34. [PMID: 31821639 DOI: 10.1002/nau.24111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
14 Langdale CL, Hokanson JA, Milliken PH, Sridhar A, Grill WM. Stimulation of the pelvic nerve increases bladder capacity in the PGE2 cat model of overactive bladder. Am J Physiol Renal Physiol 2020;318:F1357-68. [PMID: 32308021 DOI: 10.1152/ajprenal.00068.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Afari N, Buchwald D, Clauw D, Hong B, Hou X, Krieger JN, Mullins C, Stephens-Shields AJ, Gasperi M, Williams DA; MAPP Research Network. A MAPP Network Case-control Study of Urological Chronic Pelvic Pain Compared With Nonurological Pain Conditions. Clin J Pain 2020;36:8-15. [PMID: 31794439 DOI: 10.1097/AJP.0000000000000769] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Staelin R, Koneru SN, Rawe IM. A Prospective Six-Month Study of Chronic Pain Sufferers: A Novel OTC Neuromodulation Therapy. Pain Res Manag 2019;2019:3154194. [PMID: 31687056 DOI: 10.1155/2019/3154194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
17 Daily AM, Kowalik CG, Delpe SD, Kaufman MR, Dmochowski RR, Reynolds WS. Women With Overactive Bladder Exhibit More Unhealthy Toileting Behaviors: A Cross-sectional Study. Urology 2019;134:97-102. [PMID: 31499079 DOI: 10.1016/j.urology.2019.08.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Koneru SN, Staelin R, Rawe IM. Chronic pain intervention using pulsed shortwave therapy: the relationship between pain demographics and central sensitization inventory. Pain Manag 2019;9:283-96. [PMID: 31140929 DOI: 10.2217/pmt-2018-0032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Thu JHL, Vetter J, Lai HH. The Severity and Distribution of Nonurologic Pain and Urogenital Pain in Overactive Bladder are Intermediate Between Interstitial Cystitis and Controls. Urology 2019;130:59-64. [PMID: 31034917 DOI: 10.1016/j.urology.2019.03.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R, Amarenco G, Gamé X, Kirby R, Van Der Aa F, Cornu JN. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol 2019;75:988-1000. [PMID: 30922690 DOI: 10.1016/j.eururo.2019.02.038] [Cited by in Crossref: 72] [Cited by in F6Publishing: 104] [Article Influence: 24.0] [Reference Citation Analysis]
21 den Boer C, Dries L, Terluin B, van der Wouden JC, Blankenstein AH, van Wilgen CP, Lucassen P, van der Horst HE. Central sensitization in chronic pain and medically unexplained symptom research: A systematic review of definitions, operationalizations and measurement instruments. Journal of Psychosomatic Research 2019;117:32-40. [DOI: 10.1016/j.jpsychores.2018.12.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 43] [Article Influence: 12.0] [Reference Citation Analysis]
22 Sammarco AG, Kobernik EK, Haefner HK, Till SR, Berger MB. Lower Urinary Tract Symptoms in a Chronic Pelvic Pain Population. Female Pelvic Med Reconstr Surg 2020;26:712-6. [PMID: 30628949 DOI: 10.1097/SPV.0000000000000689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
23 Grundy L, Caldwell A, Brierley SM. Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome. Front Neurosci 2018;12:931. [PMID: 30618560 DOI: 10.3389/fnins.2018.00931] [Cited by in Crossref: 29] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
24 Tzeng NS, Chang HA, Chung CH, Kao YC, Yeh HW, Yeh CB, Chiang WS, Huang SY, Lu RB, Chien WC. Risk of psychiatric disorders in overactive bladder syndrome: a nationwide cohort study in Taiwan. J Investig Med 2019;67:312-8. [PMID: 30275006 DOI: 10.1136/jim-2018-000835] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
25 Ali A, Ali NS, Malik MB, Sayyed Z, Ahmad MQ. An Overview of the Pathology and Emerging Treatment Approaches for Interstitial Cystitis/Bladder Pain Syndrome. Cureus 2018;10:e3321. [PMID: 30473954 DOI: 10.7759/cureus.3321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Herrewegh A, Vork L, Eurelings E, Leue C, Kruimel J, van Koeveringe G, Vrijens D. The development of a patient-reported outcome measure for real-time symptom assessment in a population with functional urologic complaints-A focus group study. Neurourol Urodyn 2018;37:2893-903. [PMID: 30187953 DOI: 10.1002/nau.23808] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
27 Kowalik CG, Cohn JA, Delpe S, Kaufman MR, Wein A, Dmochowski RR, Reynolds WS. Painful Bladder Symptoms Related to Somatic Syndromes in a Convenience Sample of Community Women with Overactive Bladder Symptoms. J Urol 2018;200:1332-7. [PMID: 30017963 DOI: 10.1016/j.juro.2018.06.070] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
28 Neblett R. The central sensitization inventory: A user’s manual. J Appl Behav Res 2018;23:e12123. [DOI: 10.1111/jabr.12123] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
29 Reynolds WS, Kowalik C, Cohn J, Kaufman M, Wein A, Dmochowski R, Bruehl S. Women Undergoing Third Line Overactive Bladder Treatment Demonstrate Elevated Thermal Temporal Summation. J Urol 2018;200:856-61. [PMID: 29746857 DOI: 10.1016/j.juro.2018.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
30 Aydin GA, Yavuz A. Adenomyosis and urinary system symptoms. Eur J Obstet Gynecol Reprod Biol 2018;224:74-6. [PMID: 29655132 DOI: 10.1016/j.ejogrb.2018.02.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Peyronnet B, Brucker BM, Michel MC. Lower Urinary Tract Symptoms: What's New in Medical Treatment? Eur Urol Focus 2018;4:17-24. [PMID: 29665997 DOI: 10.1016/j.euf.2018.04.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
32 Cuesta-Vargas AI, Neblett R, Chiarotto A, Kregel J, Nijs J, van Wilgen CP, Pitance L, Knezevic A, Gatchel RJ, Mayer TG, Viti C, Roldan-Jiménez C, Testa M, Caumo W, Jeremic-Knezevic M, Luciano JV. Dimensionality and Reliability of the Central Sensitization Inventory in a Pooled Multicountry Sample. J Pain 2018;19:317-29. [PMID: 29198933 DOI: 10.1016/j.jpain.2017.11.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
33 Wu P, Chen Y, Zhao J, Zhang G, Chen J, Wang J, Zhang H. Urinary Microbiome and Psychological Factors in Women with Overactive Bladder. Front Cell Infect Microbiol 2017;7:488. [PMID: 29230385 DOI: 10.3389/fcimb.2017.00488] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
34 Hokanson JA, Langdale CL, Sridhar A, Grill WM. OAB without an overactive bladder in the acute prostaglandin E2 rat model. Am J Physiol Renal Physiol 2017;313:F1169-77. [PMID: 28768666 DOI: 10.1152/ajprenal.00270.2017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
35 Janssen DA, Martens FM, de Wall LL, van Breda HM, Heesakkers JP. Clinical utility of neurostimulation devices in the treatment of overactive bladder: current perspectives. Med Devices (Auckl) 2017;10:109-22. [PMID: 28615976 DOI: 10.2147/MDER.S115678] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
36 Langdale CL, Hokanson JA, Sridhar A, Grill WM. Stimulation of the pelvic nerve increases bladder capacity in the prostaglandin E2 rat model of overactive bladder. Am J Physiol Renal Physiol 2017;313:F657-65. [PMID: 28615244 DOI: 10.1152/ajprenal.00116.2017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
37 Staelin R, Koneru SN, Rawe IM. An over-the-counter central sensitization therapy: a chronic back pain registry study of pain relief, medication use and their adverse effects. Pain Management 2017;7:99-111. [DOI: 10.2217/pmt-2016-0046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
38 Reynolds WS, Brown ET, Danford J, Kaufman M, Wein A, Dmochowski R, Bruehl S. Temporal summation to thermal stimuli is elevated in women with overactive bladder syndrome. Neurourol Urodyn 2017;36:1108-12. [PMID: 27434229 DOI: 10.1002/nau.23059] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
39 Reynolds WS, Mock S, Zhang X, Kaufman M, Wein A, Bruehl S, Dmochowski R. Somatic syndromes and chronic pain in women with overactive bladder. Neurourol Urodyn 2017;36:1113-8. [PMID: 27367486 DOI: 10.1002/nau.23060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]